Cinmetacin

Cinmetacin

SCHEMBL29974302

COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)/C=C/c1ccccc1

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.68
CYP1A2 P05177 4/20 0.68
CYP2C9 P11712 4/20 0.68
HIF1A Q16665 3/20 0.68
NPSR1 Q6W5P4 3/20 0.68
TSHR P16473 3/20 0.68
CYP2D6 P10635 2/20 0.68
NFKB1 P19838 2/20 0.68
AKR1C3 P42330 8/20 0.63
AKR1C2 P52895 7/20 0.63
PLA2G2A P14555 2/20 0.59
PLA2G1B P04054 1/20 0.59
PMP22 Q01453 3/20 0.59
AKR1C4 P17516 2/20 0.59
AKR1C1 Q04828 2/20 0.59
MEN1 O00255 2/20 0.59
MAPT P10636 2/20 0.59
KMT2A Q03164 2/20 0.59
KDM4E B2RXH2 2/20 0.59
PTGS2 P35354 2/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cinmetacin SCHEMBL25138 1.00 LMNA (0.68) LMNACYP1A2CYP2C9HIF1ANPSR1
Cinmetacin SCHEMBL25139 1.00 LMNA (0.68) LMNACYP1A2CYP2C9HIF1ANPSR1
Cinmetacin SCHEMBL8636226 0.99 LMNA (0.67) LMNACYP1A2CYP2C9HIF1ANPSR1
Cinmetacin SCHEMBL8636225 0.99 LMNA (0.67) LMNACYP1A2CYP2C9HIF1ANPSR1
SCHEMBL12609001 0.93 LMNA (0.58) LMNACYP1A2CYP2C9HIF1ANPSR1
SCHEMBL3459041 0.92 PLA2G2A (0.69) LMNACYP1A2CYP2C9HIF1ANPSR1
SCHEMBL12628642 0.92 AKR1C3 (0.62) LMNACYP1A2CYP2C9HIF1ANPSR1
SCHEMBL13849829 0.91 PTGS2 (0.61) LMNACYP1A2CYP2C9HIF1ANPSR1
SCHEMBL9815440 0.89 LMNA (0.53) LMNACYP1A2CYP2C9HIF1ANPSR1
SCHEMBL9815439 0.89 LMNA (0.53) LMNACYP1A2CYP2C9HIF1ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117015601-A Methods and compositions for ADAR-mediated SERPINA1 editing 科罗生物公司 2023-11-07 CN disclosed
CN-115175667-A Lipid vesicle composition with permeation enhancer 迪迪艾斯研究公司 2022-10-11 CN disclosed